BioCentury | Mar 15, 2021
Deals

Roche ramps up fast-growing infectious Dx segment with $1.8B takeout of GenMark

...recent Roche deal for an infectious disease diagnostics company came in 2015 when Roche acquired GeneWeave BioSciences Inc....
BioCentury | Jun 6, 2016
Finance

Rushing to America

...The biotech focused on tools for single-cell genetic analysis. Roche bought infectious disease diagnostics company GeneWeave Biosciences Inc....
...million in milestones. "Prior to the acquisition, we were working on a China strategy for GeneWeave,"...
BioCentury | Aug 24, 2015
Strategy

Green light for GeneWeave

...Roche is buying GeneWeave Biosciences Inc. to beef up the diagnostics side of its infectious disease initiative with...
...said. Under the Aug. 13 deal, the pharma will pay $190 million up front and GeneWeave...
...said, adding that all of GeneWeave's employees have been offered positions at Roche Molecular Diagnostics. GeneWeave...
BioCentury | Aug 17, 2015
Company News

GeneWeave, Roche deal

...Roche will acquire GeneWeave for $190 million up front and up to $235 million in milestones...
...for $190 million up front and up to $235 million in milestones. Roche will gain GeneWeave’s...
...detect multi-drug resistant organisms including methicillin-resistant Staphylococcus aureus (MRSA) directly from clinical samples. vivoDx uses GeneWeave’s...
BioCentury | Aug 14, 2015
Top Story

Roche acquiring GeneWeave

...Roche (SIX:ROG; OTCQX:RHHBY) will acquire diagnostic play GeneWeave Biosciences Inc. (Los Gatos, Calif.) for $190 million up front...
...for $190 million up front and up to $235 million in milestones. Roche will gain GeneWeave's...
...detect multi-drug resistant organisms including methicillin-resistant Staphylococcus aureus (MRSA) directly from clinical samples. vivoDx uses GeneWeave's...
BioCentury | Jul 14, 2014
Financial News

GeneWeave Biosciences Inc completes venture financing

GeneWeave Biosciences Inc ., Los Gatos, Calif. Business: Diagnostic Date completed: 2014-07-02 Type: Venture financing Raised: $12 million Investors: Decheng Capital; Claremont Creek Ventures; XSeed Capital WIR Staff Diagnostic...
BioCentury | Jul 9, 2014
Financial News

GeneWeave raises $12 million series B

...Diagnostic company GeneWeave Biosciences Inc. (Los Gatos, Calif.) raised $12 million in a series B round led by...
...by existing investor Decheng Capital. Existing investors Claremont Creek Ventures and XSeed Capital also participated. GeneWeave...
...does not use nucleic acid amplification or require sample preparation and has very few steps. GeneWeave...
BioCentury | Mar 5, 2012
Company News

GeneWeave board of directors update

GeneWeave Biosciences Inc. , San Jose, Calif. Business: Diagnostic Appointed: Min Cui, managing director at Decheng Capital LLC WIR Staff Diagnostic...
BioCentury | Mar 5, 2012
Finance

Weaving in China

...Weaving in China Last week's $12 million series A round for molecular diagnostics play GeneWeave Biosciences Inc. is...
...said, Decheng Capital came to the deal thinking about China as a potential market for GeneWeave...
...market that we had not fully recognized," said Driscoll. As a platform company, Driscoll thinks GeneWeave...
BioCentury | Mar 5, 2012
Financial News

GeneWeave completes venture financing

GeneWeave Biosciences Inc. , San Jose, Calif. Business: Diagnostic Date completed: 2/28/12 Type: Venture financing Raised: $12 million Investors: Decheng Capital; Claremont Creek Ventures; X/Seed Capital WIR Staff...
Items per page:
1 - 10 of 11
BioCentury | Mar 15, 2021
Deals

Roche ramps up fast-growing infectious Dx segment with $1.8B takeout of GenMark

...recent Roche deal for an infectious disease diagnostics company came in 2015 when Roche acquired GeneWeave BioSciences Inc....
BioCentury | Jun 6, 2016
Finance

Rushing to America

...The biotech focused on tools for single-cell genetic analysis. Roche bought infectious disease diagnostics company GeneWeave Biosciences Inc....
...million in milestones. "Prior to the acquisition, we were working on a China strategy for GeneWeave,"...
BioCentury | Aug 24, 2015
Strategy

Green light for GeneWeave

...Roche is buying GeneWeave Biosciences Inc. to beef up the diagnostics side of its infectious disease initiative with...
...said. Under the Aug. 13 deal, the pharma will pay $190 million up front and GeneWeave...
...said, adding that all of GeneWeave's employees have been offered positions at Roche Molecular Diagnostics. GeneWeave...
BioCentury | Aug 17, 2015
Company News

GeneWeave, Roche deal

...Roche will acquire GeneWeave for $190 million up front and up to $235 million in milestones...
...for $190 million up front and up to $235 million in milestones. Roche will gain GeneWeave’s...
...detect multi-drug resistant organisms including methicillin-resistant Staphylococcus aureus (MRSA) directly from clinical samples. vivoDx uses GeneWeave’s...
BioCentury | Aug 14, 2015
Top Story

Roche acquiring GeneWeave

...Roche (SIX:ROG; OTCQX:RHHBY) will acquire diagnostic play GeneWeave Biosciences Inc. (Los Gatos, Calif.) for $190 million up front...
...for $190 million up front and up to $235 million in milestones. Roche will gain GeneWeave's...
...detect multi-drug resistant organisms including methicillin-resistant Staphylococcus aureus (MRSA) directly from clinical samples. vivoDx uses GeneWeave's...
BioCentury | Jul 14, 2014
Financial News

GeneWeave Biosciences Inc completes venture financing

GeneWeave Biosciences Inc ., Los Gatos, Calif. Business: Diagnostic Date completed: 2014-07-02 Type: Venture financing Raised: $12 million Investors: Decheng Capital; Claremont Creek Ventures; XSeed Capital WIR Staff Diagnostic...
BioCentury | Jul 9, 2014
Financial News

GeneWeave raises $12 million series B

...Diagnostic company GeneWeave Biosciences Inc. (Los Gatos, Calif.) raised $12 million in a series B round led by...
...by existing investor Decheng Capital. Existing investors Claremont Creek Ventures and XSeed Capital also participated. GeneWeave...
...does not use nucleic acid amplification or require sample preparation and has very few steps. GeneWeave...
BioCentury | Mar 5, 2012
Company News

GeneWeave board of directors update

GeneWeave Biosciences Inc. , San Jose, Calif. Business: Diagnostic Appointed: Min Cui, managing director at Decheng Capital LLC WIR Staff Diagnostic...
BioCentury | Mar 5, 2012
Finance

Weaving in China

...Weaving in China Last week's $12 million series A round for molecular diagnostics play GeneWeave Biosciences Inc. is...
...said, Decheng Capital came to the deal thinking about China as a potential market for GeneWeave...
...market that we had not fully recognized," said Driscoll. As a platform company, Driscoll thinks GeneWeave...
BioCentury | Mar 5, 2012
Financial News

GeneWeave completes venture financing

GeneWeave Biosciences Inc. , San Jose, Calif. Business: Diagnostic Date completed: 2/28/12 Type: Venture financing Raised: $12 million Investors: Decheng Capital; Claremont Creek Ventures; X/Seed Capital WIR Staff...
Items per page:
1 - 10 of 11